Drug safety in Indonesia
Drug Safety in Developing Countries, Page: 279-285
2020
- 3Citations
- 28Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
This chapter aims to explore the drug (medication) safety-related issues in Indonesia, highlighting present practices and reporting challenges and offering recommendations to overcome the challenges. Medication safety practice in Indonesia faces several challenges related to pharmacovigilance: adverse drug reactions and their reporting; medication errors; self-medication; and other safety issues. Improving the medication safety system and including all medication safety activities; education in terms of continuous professional development and programs; research into medication safety issues; awareness programs for health care professionals and public; regulations and guidelines and international collaboration are highly recommended to improve the medication safety practice in Indonesia.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780128198377000236; http://dx.doi.org/10.1016/b978-0-12-819837-7.00023-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85093986744&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/B9780128198377000236; https://dx.doi.org/10.1016/b978-0-12-819837-7.00023-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know